BioXell announces change in management
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Milan, Italy, 1 December 2009 - BioXell S.p.A. (SIX: BXLN) announcedtoday the termination of the working relationship with Laurence H.Skillern, Chief Medical Officer.Mr. Skillern joined BioXell as Chief Medical Officer as of February1, 2009. His function has been terminated by both parties by mutualagreement effective November 30, 2009.About BioXellBioXell S.p.A. (SIX: BXLN) is a listed biopharmaceutical company thatfocused on the discovery and development of drugs that exploit novelmechanisms of action. The Company is currently pursuing efforts tooutlicense its monoclonal antibody BXL1H5 for the treatment ofchronic pain. On 18 November 2009, BioXell announced that its Boardof Directors supports the intended public takeover by CosmoPharmaceuticals S.p.A. The offer is expected to be launched inDecember 2009 and will be closed in March 2010.BioXell was founded in 2002 as a spin-out from Roche. In June 2006,BioXell listed its shares on the main segment of the SIX SwissExchange. The Company is located in Milan, Italy.More information on BioXell can be found at: www.bioxell.comFor further information, please contact:BioXellDynamics Group SAAlvise Sagramoso, Chief AdministrativeOfficer Christophe LampsTel: +39 (0)2 210 49550 Tel:+41 (0)22 308 62 22Fax: +39 (0)2 700 59926Fax: +41 (0)22 308 62 36alvise.sagramoso(at)bioxell.com cla(at)dynamicsgroup.chThis press release can be downloaded at www.bioxell.com.DisclaimerThis press release does not constitute or form part, or all, of anyoffer or invitation to sell or issue, or any solicitation of anyoffer to purchase or subscribe for, any securities, nor shall part,or all, of these materials or their distribution form the basis of,or be relied on in connection with, any contract or investmentdecision in relation to any securities. This press release containsforward-looking statements based on the currently held beliefs andassumptions of the management of BioXell, which are expressed in goodfaith and, in their opinion, reasonable. Forward-looking statementsinvolve known and unknown risks, uncertainties and other factors,which may cause the actual results, financial condition, performance,or achievements of BioXell, or industry results, to differ materiallyfrom the results, financial condition, performance or achievementsexpressed or implied by such forward-looking statements. Given theserisks, uncertainties and other factors, recipients of this documentare cautioned not to place undue reliance on these forward-lookingstatements. BioXell disclaims any obligation to update theseforward-looking statements to reflect future events or developments.http://hugin.info/133681/R/1358371/330696.pdf --- End of Message ---bioXell S.p.Avia Olgettina 58 Milan ItalyWKN: A0J3MW; ISIN: IT0004069933 ; Listed: Main Market in SIX Swiss Exchange;
Datum: 01.12.2009 - 18:00 Uhr
Sprache: Deutsch
News-ID 9117
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 458 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioXell announces change in management"
steht unter der journalistisch-redaktionellen Verantwortung von
bioXell S.p.A (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
